Selecta Biosciences, Inc. Profile Avatar - Palmy Investing

Selecta Biosciences, Inc.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program …

Biotechnology
US, Watertown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SELB's Analysis
CIK: 1453687 CUSIP: 816212104 ISIN: US8162121045 LEI: - UEI: -
Secondary Listings
SELB has no secondary listings inside our databases.